Stock 6L7A BELLEROPHON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Bellerophon Therapeutics, Inc. Börse Stuttgart

Equities

6L7A

US0787713009

Market Closed - Börse Stuttgart
Other stock markets
 02:01:13 2023-10-13 EDT 		5-day change 1st Jan Change
0.421 EUR +20.98% Intraday chart for Bellerophon Therapeutics, Inc. +26.05% -45.08%
05-02 North American Morning Briefing : Stock Futures -2- DJ
04-25 North American Morning Briefing : More Tech -2- DJ

Evolution of the average Target Price on Bellerophon Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

dc6d8abf36d479bd88292.1LTM58wsncUmpJDu0SXYqqIRcx0c5H8bqpnWytnIvBY.uvyphLRf1IoTwNGqlFCd3_E8I1521gt88_Gx-Oyg5l-z_pnQvhr7h2L-xQ~f2bb41397868ed141d85adcb8d77d355

Analyst Recommendations on Bellerophon Therapeutics, Inc.

North American Morning Briefing : More Tech -2- DJ
North American Morning Briefing : Stocks Futures Steady on Rates Optimism DJ
HC Wainwright Adjusts Bellerophon Therapeutics Price Target to $2 From $30, Maintains Buy Rating MT
Brookline Capital Downgrades Bellerophon Therapeutics to Hold From Buy MT
Laidlaw Downgrades Bellerophon Therapeutics to Hold From Buy MT
Laidlaw Initiates Bellerophon Therapeutics at Buy With $35 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.056
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Bellerophon Therapeutics, Inc.

HC Wainwright
Laidlaw & Co.
Brookline Capital Markets

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BLPH Stock
  4. 6L7A Stock
  5. Consensus Bellerophon Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW